Comparison of Mirabegron plus Tamsulosin and Tamsulosin Monotherapy for the Treatment of Ureteral Stent-Related Symptoms: A Prospective Randomized Study.

Zhang, Kai; Yan, Wei; Li, Hongbo; Chen, Jie; Wang, Qian; Chai, Yali; Yuan, Lihua; Zhu, Gang

Zhang, Kai; Yan, Wei; Li, Hongbo; Chen, Jie; Wang, Qian; Chai, Yali; Yuan, Lihua; Zhu, Gang.

Afiliação

Zhang K; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China, zhangkai449@126.com.
Yan W; Department of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Li H; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China.
Chen J; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China.
Wang Q; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China.
Chai Y; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China.
Yuan L; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China.
Zhu G; Department of Urology, Beijing United Family Hospital and Clinics, Beijing, China.

Urol Int ; 106(12): 1226-1232, 2022.

Article em En | MEDLINE | ID: mdl-36244331

Assuntos

Qualidade de Vida; Stents; Humanos; Tansulosina/uso terapêutico; Estudos Prospectivos; Dor

Palavras-chave

Lithotripsy; Mirabegron; Pain control; Tamsulosin; Ureteral stent

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Stents Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Urol Int Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google